1-(4-溴苯基)环戊烷甲腈 | 143328-19-2

• 物质功能分类: 医药中间体 - 杂环化合物
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 1-(4-溴苯基)环戊烷甲腈
• 英文名称: 1-(4-bromophenyl)cyclopentane-1-carbonitrile
• 英文别名: 1-(4-bromophenyl)cyclopentanecarbonitrile
• CAS: 143328-19-2
• 化学式: C₁₂H₁₂BrN
• mdl: MFCD01536834
• 分子量: 250.138
• InChiKey: NLHJLQZXHOLSBX-UHFFFAOYSA-N

物化性质

• 沸点：
  351.3±35.0 °C(Predicted)
• 密度：
  1.41±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.7
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.416
• 拓扑面积：
  23.8
• 氢给体数：
  0
• 氢受体数：
  1

安全信息

• 海关编码：
  2926909090
• 储存条件：
  存放条件：室温、密封、干燥。

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 1-(4-Bromophenyl)cyclopentanecarbonitrile
Synonyms: 4-(1-Cyanocyclopentyl)bromobenzene

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 1-(4-Bromophenyl)cyclopentanecarbonitrile
CAS number: 143328-19-2

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C12H12BrN
Molecular weight: 250.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen bromide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  1-(4-溴苯基)环戊烷甲腈 在 吡啶 、 盐酸 、 甲醇 、 sodium tetrahydroborate 、 lithium hydroxide monohydrate 、 三甲基铝 、 sodium methylate 、 二异丁基氢化铝 、 氯化铵 、 三乙胺 、 三苯基膦 、 potassium iodide 、 偶氮二甲酸二乙酯 、 三氯氧磷 作用下， 以 四氢呋喃 、 甲醇 、 二氯甲烷 、 水 、 二甲基亚砜 、 甲苯 为溶剂， 反应 66.5h， 生成 9-benzyloxy-6-[1-(4-bromophenyl)cyclopentylmethyl]-2-isopropyl-3,4-dihydro-2H-pyrazino[1,2-c]pyrimidine-1,8-dione
  参考文献：
  名称：

  PYRIMIDONE DERIVATIVES AND THEIR USE IN THE TREATMENT, AMELIORATION OR PREVENTION OF A VIRAL DISEASE

  摘要：

  本发明涉及具有通式（I）的化合物，可选地以药学上可接受的盐、溶剂合物、多型体、共药、共晶、前药、互变异构体、外消旋体、对映体或二对映体或其混合物的形式出现，这些化合物在治疗、缓解或预防病毒性疾病方面是有用的。此外，还披露了特定的联合疗法。

  公开号：

  US20140194431A1
• 作为产物：
  描述：

  1,4-二溴丁烷 、 对溴苯乙腈 在 sodium hydride 作用下， 以 乙醚 、 二甲基亚砜 为溶剂， 反应 14.0h， 以61%的产率得到1-(4-溴苯基)环戊烷甲腈
  参考文献：
  名称：

  在室温下生物启发的α支链脂肪醛的无金属形式脱羰

  摘要：

  通过一系列的Baeyer-Villiger氧化和Lewis酸促进的Et 3 SiH甲酸还原反应，可实现叔和仲脂族醛的无金属正式脱羰作用。这种新方法模仿了传统的Tsuji-Wilkinson型反应中已知的通过氧化C-C键裂解而不是C（O）-H键活化的生物合成脱羰途径。底物范围是对现有过渡金属催化方案的补充。

  DOI：

  10.1002/chem.201902082

文献信息

• [EN] OXADIAZOLE INHIBITORS OF LEUKOTRIENE PRODUCTION<br/>[FR] COMPOSÉS OXADIAZOLE, INHIBITEURS DE LA PRODUCTION DE LEUCOTRIÈNES
  申请人：BOEHRINGER INGELHEIM INT

  公开号：WO2012027322A1

  公开（公告）日：2012-03-01

  The present invention relates to compound of formula (I) and pharmaceutically acceptable salt thereof, wherein R1-R5 are as defined herein. The invention also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes.

  本发明涉及式(I)的化合物及其药用可接受盐，其中R1-R5如本文所定义。该发明还涉及包括这些化合物的药物组合物，使用这些化合物治疗各种疾病和疾病的方法，制备这些化合物的过程以及在这些过程中有用的中间体。
• CHEMOSELECTIVE METHYLENE HYDROXYLATION IN AROMATIC MOLECULES
  申请人：The Board of Trustees of the University of Illinois

  公开号：US20200087331A1

  公开（公告）日：2020-03-19

  A chemoselective and reactive Mn(CF 3 -PDP) catalyst system that enables for the first time the strategic advantages of late-stage aliphatic C—H hydroxylation to be leveraged in aromatic compounds. This discovery will benefit small molecule therapeutics by enabling the rapid diversification of aromatic drugs and natural products and identification of their metabolites.

  一种化学选择性和反应性的Mn(CF3-PDP)催化体系首次实现了后期脂肪族C—H羟基化在芳香化合物中的战略优势。这一发现将有助于小分子药物的快速多样化和芳香类药物以及天然产物的代谢产物的鉴定。
• 酰胺化合物及其衍生物，制备方法、药物组合物和应用
  申请人：中国药科大学

  公开号：CN113061098B

  公开（公告）日：2022-08-30

  本发明公开了一类酰胺化合物及其衍生物，制备方法、药物组合物和应用。该类酰胺化合物结构如式(I)，该类酰胺化合物衍生物涉及所述酰胺化合物的立体异构体、互变异构体、代谢产物、代谢前体、前药、溶剂化物、溶剂化物的盐、结晶、药学上可接受的盐或它们的混合物。该类酰胺化合物及其衍生物对吲哚胺2,3‑双加氧酶1具有高效的抑制作用，可用于制备治疗吲哚胺2,3‑双加氧酶1介导的免疫抑制相关疾病的药物，所制备药物在分子水平即可发挥药效，应用广泛，并且该类化合物合成方法简便，易操作。
• Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benzopyrans
  申请人：——

  公开号：US20020193410A1

  公开（公告）日：2002-12-19

  This invention is directed to substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benzopyrans that inhibit Factor Xa, pharmaceutical compositions comprising these compounds and their use for inhibiting Factor Xa or treating pathological conditions in a patient that may be ameliorated by administration of such compounds. This invention is also is also directed to substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benzopyrans which directly inhibit both Factor Xa and Factor IIa (thrombin), to pharmaceutical compositions comprising these compounds, to intermediates useful for preparing these compounds and to a method of simultaneously directly inhibiting both Factor Xa and Factor IIa (thrombin).

  这项发明涉及取代的（氨基亚甲基或氨甲基）二氢苯并呋喃和苯并吡喃，这些化合物抑制因子Xa，包括这些化合物的药物组合物以及它们用于抑制因子Xa或治疗可以通过给予这些化合物改善的患者的病理状况。这项发明还涉及取代的（氨基亚甲基或氨甲基）二氢苯并呋喃和苯并吡喃，直接抑制因子Xa和因子IIa（凝血酶），包括这些化合物的药物组合物，用于制备这些化合物的中间体，以及同时直接抑制因子Xa和因子IIa（凝血酶）的方法。
• Chemoselective methylene oxidation in aromatic molecules
  作者：Jinpeng Zhao、Takeshi Nanjo、Emilio C. de Lucca、M. Christina White

  DOI：10.1038/s41557-018-0175-8

  日期：2019.3

  labile aromatic functionalities remains a major unsolved problem. Such chemoselective reactivity is highly desirable for enabling late-stage oxidative derivatizations of pharmaceuticals and medicinally important natural products that often contain such functionality. Here, we report a simple manganese small-molecule catalyst Mn(CF3–PDP) system that achieves such chemoselectivity via an unexpected synergy

  尽管在过去十年中，位点选择性脂肪族C–H氧化的发展取得了重大进展，但是在存在更多易氧化的芳族官能团的情况下，能够氧化亚甲基C–H强键的能力仍然是一个主要未解决的问题。这种化学选择性反应性对于使通常包含这种功能性的药物和重要的天然药物能够进行后期的氧化衍生化是非常需要的。在这里，我们报告了一种简单的锰小分子催化剂Mn（CF 3-PDP）系统通过催化剂设计和酸添加剂的意外协同作用实现了这种化学选择性。在50种芳香族化合物中可进行制备型亚甲基远距离氧化，这些芳香族化合物具有可药用的卤素，氧，杂环和联芳基部分。在四种药物支架上均显示了晚期亚甲基氧化，包括乙炔雌二醇支架，在该支架上，其他可耐受芳香族基团的非定向CH氧化剂仅在活化的叔苄基位上进行氧化。证明了从高级中间体快速生成已知代谢物（吡拉格列汀）的方法。